Not only is SREBP2 related to the progression of Alzheimer’s disease through the production of cholesterol, it is also directly involved in the regulation of certain genes that contribute to amyloid-beta and tau protein generation. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.